Vaishali Pharma Limited (NSE:VAISHALI)

Market Cap	1.40B
Revenue (ttm)	1.02B
Net Income (ttm)	8.17M
Shares Out	120.94M
EPS (ttm)	0.31
PE Ratio	37.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,494
Average Volume	577,510
Open	11.55
Previous Close	11.54
Day's Range	11.49 - 11.74
52-Week Range	10.30 - 24.91
Beta	0.30
RSI	33.92
Earnings Date	Jul 29, 2025

About Vaishali Pharma

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 27
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VAISHALI

Financial Performance

In 2024, Vaishali Pharma's revenue was 1.02 billion, an increase of 18.49% compared to the previous year's 862.80 million. Earnings were 8.17 million, an increase of 13.69%.